Vomitinib should be taken on an empty stomach, and it is recommended that it be taken once daily on an empty stomach 1 hour before breakfast and at the same time each day to avoid forgetting.
Vomitinib is used in adult patients with advanced non-small cell lung cancer who have experienced disease progression after previous treatment with an epidermal growth factor tyrosine kinase inhibitor and have a confirmed EGFR-T790M mutation.
This product is usually taken once a day, two tablets at a time, and it is recommended that you take it about an hour before breakfast each day to try to avoid missing it. Take the tablets whole, not broken or crushed.
Adverse reactions of this product include rash, urticaria, cardiac arrhythmia, generalized itching, atrioventricular block, etc. It is contraindicated for those who are allergic to this product.
Please use the drug according to the doctor’s instructions under the guidance of the physician, and should not blindly use the drug by yourself.